¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà)´ëÇÑ°ñ´Ù°øÁõÇÐȸ ±¹Á¦Çмú´ëȸ ICO2021 (2ÀÏÂ÷) : 2021-11-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà)´ëÇÑ°ñ´Ù°øÁõÇÐȸ ±¹Á¦Çмú´ëȸ ICO2021 (2ÀÏÂ÷) : 2021-11-06
±³À°ÀÏÀÚ : 2021-11-06
±³À°Àå¼Ò : (¿Â-¿ÀÇÁ¶óÀÎ º´Çà) ¼­¿ïµå·¡°ï½ÃƼȣÅÚ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà)´ëÇÑ°ñ´Ù°øÁõÇÐȸ ±¹Á¦Çмú´ëȸ ICO2021 (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ°ñ´Ù°øÁõÇÐȸ
´ã´çÀÚ : ¿À¼ºÈñ
¿¬¶ôó : 02-777-9896  
À̸ÞÀÏ : work@koreanosteoporosis.or.kr      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤½Å°Ç°­ÀÇÇаú, ½Å°æ¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаúÀÇ»çÇÐ, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥  
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 10 ½Ã°£ 45ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ $100, °£È£»ç, Àü°øÀÇ $50 ÇöÀåµî·Ï : Àü¹®ÀÇ $120. °£È£»ç, Àü°øÀÇ $70      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 09:00~09:20 Drug development: Inhibition of exosome secretion from cancer cells  Moonchang Baek (Korea)(°æºÏÀÇ´ë) 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 09:20~09:40 Diagnosis and therapy of bone metastasis via elucidation of bone-specific tumor microenvironment  Serkin Park(Korea)(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 09:40~10:00 High-phytate/low-calcium diet is a risk factor for phosphate overloading and for the development of crystal nephropathies and bone disease.  Byung-Chul Oh (Korea)(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 10:00~10:20 Parathyroid hormone ameliorates temporomandibular joint osteoarthritic-like changes related to age.  Liwei Zheng(China)(Sichuan University) 
Åä·Ð 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 10:20~10:35 Discussion  () 
È޽Ġ11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 10:35~10:55 Coffee Break  () 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 10:55~11:25 Molecular mechanism of osteoporosis treatment  Sakae Tanaka (Japan)(The University of Tokyo) 
Åä·Ð 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 11:25~11:35 Discussion  () 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 11:40~12:00 future and present of medical treatment of osteoporosis  Mattias Lorentzon (Sweden/ECTS)(Sahlgrenska University Hospital) 
Åä·Ð 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 11:35~11:50 Discussion  () 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 11:50~13:00 Á¡½É½Ä»ç  () 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 13:00~13:20 Assessment of finite element models for prediction of osteoporotic fracture  Tae Yong Lee (Korea)(ÀÌÈ­°ø´ë ±âÃÊ) 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 13:20~13:40 FRAX-based intervention thresholds in Asia  Sarath Lekamwasam (Sri Lanka)(Department of Medicine, Faculty of Medicine, Galle, Sri Lanka) 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 13:40~14:00 DXA monitoring with TBS: The 2019 ISCD official positions  Yoon-Sok Chung (Korea)(¾ÆÁÖÀÇ´ë ) 
È޽Ġ11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 14:00~14:20 Changes in BMD and fracture risk during osteoporosis treatment  Cyrus Cooper (UK / ECTS )(University of Southampton) 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 14:20~14:35 Discussion  () 
È޽Ġ11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 14:35~14:55 Coffee Break  () 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 14:55~15:25 future and present of medical treatment of osteoporosis  Mattias Lorentzon (Sweden/ECTS)(Sahlgrenska University Hospital) 
Åä·Ð 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 15:25~15:35 Discussion  () 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 15:35~16:05 Pathopphysiology of osteopenia in RA  Roland Chapurlat (France / ECTS)(Hôpital E Herriot) 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 16:05~16:35 Management of osteoporosis in RA  Yoon-Kyoung Sung(Korea)(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 16:35~17:05 Effects of medical treatment of RA on bone  Cyrus Cooper (UK / ECTS )(University of Southampton) 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 17:05~17:35 Surgeon  Sang-Il Kim (Korea)(°¡Å縯ÀÇ´ë) 
Åä·Ð 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 17:35~18:00 Discussion  () 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 15:35~16:05 Basal concepts of treat-to-target approach for osteoporosis  Mattias Lorentzon (Sweden / ECTS)(Sahlgrenska University Hospital) 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 16:05~16:35 Metabolomics of osteoporosis  Ching-Lung Cheung (Hong Kong)(LKS Faculty of Medicine) 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 16:35~17:05 Development of fracture liaison service in Taiwan  Derrick Ding-Cheng Chan (Taiwan)(NTU Hsin-Chu Hospital) 
±³À°½Ã°£ 11-06 ¼­¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 17:05~17:35 Management of femur fracture - who should avoid operation?  Kwang Joon Kim (Korea)(¿¬¼¼ÀÇ´ë) 
Åä·Ð 11-06  17:35~18:00 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà)´ëÇÑ°ñ´Ù°øÁõÇÐȸ ±¹Á¦Çмú´ëȸ ICO2021 (2ÀÏÂ÷) : 2021-11-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2021³â ´Ü±¹´ëº´¿ø ³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2021-11-06
´ÙÀ½±Û (¿Â¶óÀÎ) Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥ : 2021-11-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
360 ¼­¿ï ´ëÇÑÀçÈ°ÀÇÇаúÀÇ»çȸ 2018 Ãß°èÇмú´ëȸ : 2018-09-09 1 1,038 2018-08-08
359 ¼­¿ï 2018³âµµ ³úÆÄÁ¤µµ°ü¸®À§¿øȸ Á¤±â±³À° : 2018-09-09 0 662 2018-08-08
358 °æ³² Á¦1ȸ µ¿ºÎ°æ³²Çмú´ëȸ : 2018-09-08 0 846 2018-08-08
357 ¼­¿ï °æÈñ´ëÇб³º´¿ø ¹é¹ÝÁõ°ú »ö¼ÒÁúȯ : 2018-09-08 0 829 2018-08-08
356 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ Asthma School 2018 : 2018-09-08 0 365 2018-08-08
355 ¼­¿ï 2018³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-08 0 396 2018-08-08
354 ºÎ»ê 2018 ´ëÇѾȰúÀÇ»çȸ 5Â÷ ½ÉÆ÷Áö¿ò : 2018-09-08 0 716 2018-08-08
353 ºÎ»ê ´ëÇÑôÃß¿Ü°úÇÐȸ ºÎ¿ï°æ ´ë±¸ÇÕµ¿ ôÃßÁöȸ ¼¼¹Ì³ª : 2018-09-08 0 573 2018-08-08
352 ±¤ÁÖ ´ëÇÑôÃß¿Ü°úÇÐȸ 2018 ±¤ÁÖ±¹Á¦Ã´Ãß½ÉÆ÷Áö¿ò : 2018-09-08 0 304 2018-08-08
351 ÃæºÏ Á¦14Â÷ ´ëÀüÃæû¼Ò¾Æ½Å°æÁöȸ ½ÉÆ÷Áö¾ö : 2018-09-08 0 719 2018-08-08
350 ¼­¿ï 2018³â ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2018-09-07 0 718 2018-08-08
349 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú ±Ý¿äÁý´ãȸ : 2018-09-07 0 445 2018-08-08
348 ºÎ»ê ÁÁÀº°­¾Èº´¿ø Áø·á½Ç¿¡¼­ ÈçÈ÷ º¸´Â Áõ»óÀÇ Á¢±Ù°ú Ä¡·á : 2018-09-06 0 602 2018-08-08
347 ºÎ»ê ´ëÇѺñ´¢±â°úÇÐȸ ¼Ò¾Æºñ´¢ÀÇÇÐ ¹× ³²¼ºÀÇÇÐ : 2018-09-06 0 840 2018-08-08
346 ±¤ÁÖ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Á¦281Â÷ Àü³²Áöȸ Áý´ãȸ : 2018-09-06 0 364 2018-08-08
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷